FIELD: biotechnologies.
SUBSTANCE: invention proposed N-end fragment of soluble suppressor of immune response with the length of 21 amino-acids, which has sequence of amino-acids as per Seq ID NO: 1, allowing to promote formation of regulatory T-lymphocytes, as well as a promotion method of formation of regulatory T-lymphocytes with N-end fragment of soluble suppressor of immune response with Seq ID NO: 1, at its introduction with the concentration of 0.1-50 microgram/ml.
EFFECT: invention can be used for propagation of regulatory T-lymphocytes obtained from a patient suffering autoimmune disease, for the purpose of further injection of the obtained T-lymphocytes into the body of the patient.
3 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES MEDIATED BY REGULATORY T-CELLS | 2017 |
|
RU2727900C2 |
NEW SUBPOPULATION OF TREG CD8CD45RC CELLS AND ITS APPLICATIONS | 2016 |
|
RU2766691C2 |
MEDICATION, INTENDED FOR TREATMENT AND/OR PREVENTION OF AUTOIMMUNE DISEASE AND FOR FORMATION OF REGULATORY N-CELLS | 2009 |
|
RU2531936C2 |
METHODS FOR IDENTIFICATION, SELECTION, ENRICHMENT AND DEPLETION OF Tr1 CELLS POPULATIONS, Tr1 CELLS POPULATIONS, PHARMACEUTICAL COMPOSITIONS, METHODS FOR THERAPY EFFECT MONITORING | 2011 |
|
RU2627445C2 |
THYMUS-SPECIFIC PROTEIN | 2005 |
|
RU2535971C2 |
DRUGS FOR TREATING DISEASES | 2010 |
|
RU2598719C2 |
THYMUS-SPECIFIC PROTEIN | 2005 |
|
RU2398776C2 |
SOLUBLE MEDIATOR | 2012 |
|
RU2660580C2 |
SYSTEM AND METHOD OF OBTAINING AND STORAGE OF ACTIVATED MATURE DENDRITIC CELLS | 2011 |
|
RU2575978C2 |
REDUCED LEVELS OR ACTIVITY OF SYSTEMIC REGULATORY T CELLS FOR TREATING DISEASE OR CNS INJURY | 2015 |
|
RU2690670C2 |
Authors
Dates
2013-11-20—Published
2012-09-26—Filed